AMP- activated Protein Kinase (AMPK) a serine/threonine protein kinase has been postulated as an important drug target in metabolic syndrome and diabetes because of its role in regulation of cellular energy metabolic homeostasis. This evidence concerns the gene PRKAA2 and diabetes mellitus.